ADORA2A and non-small cell lung carcinoma: There were no significant differences in CD73/A2AR expression levels according to disease stage and, in contrast to the entire NSCLC cohort, A2AR expression levels did not differ significantly according to the intensity of immune cell infiltration (Supplementary Figure 1B).